Form 4 for TXN Texas Instruments
Accepted 2025-02-20 00:00:00 ET · period of report 2025-02-19 · accession 0001127602-25-005930 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-20 | 2025-02-19 | TXN | BLINN MARK A | Dir | M - OptEx | $171.55 | +6,186 | 17.1K | +56% | +$1.06M |
| D | 2025-02-20 | 2025-02-19 | TXN | BLINN MARK A | Dir | S - Sale+OE | $189.89 | -6,186 | 11.7K | -35% | -$1.17M |
| DM | 2025-02-20 | 2025-02-19 | TXN | BLINN MARK A | Dir | M - OptEx | $0.00 | -6,186 | 2,300 | -73% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-19 | M | A | 2,457 | $169.23 | 14,174 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-19 | M | A | 1,884 | $174.81 | 16,058 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-19 | M | A | 766 | $167.42 | 17,903 | D | — | — | |
| 4 | Common | Common Stock | 2025-02-19 | S | D | 6,186 | $189.89 | 11,717 | D | — | — | (F1) The price in Table 1 is a weighted average sale price. The sales were at prices ranging from $189.75 to $190.105. The Issuer undertakes to provide upon request a detailed breakout of the sale prices and the number of shares sold at each price. |
| 5 | Common | Common Stock | 2025-02-19 | M | A | 1,079 | $174.10 | 17,137 | D | — | — | |
| 6 | Derivative | NQ Stock Option (Right to Buy) | 2025-02-19 | M | D | 1,079 | $0.00 | 1,080 | D | $174.10 · — to 2033-01-26 | 1,079 Common Stock | (F8) The option became exercisable in four equal annual installments beginning on January 26, 2024. |
| 7 | Derivative | NQ Stock Option (Right to Buy) | 2025-02-19 | M | D | 1,884 | $0.00 | 628 | D | $174.81 · — to 2032-01-27 | 1,884 Common Stock | (F7) The option became exercisable in four equal annual installments beginning on January 27, 2023. |
| 8 | Derivative | NQ Stock Option (Right to Buy) | 2025-02-19 | M | D | 2,457 | $0.00 | 0 | D | $169.23 · — to 2031-01-28 | 2,457 Common Stock | (F6) The option became exercisable in four equal annual installments beginning on January 28, 2022. |
| 9 | Derivative | NQ Stock Option (Right to Buy) | 2025-02-19 | M | D | 766 | $0.00 | 2,300 | D | $167.42 · — to 2034-01-25 | 766 Common Stock | (F9) The option became exercisable in four equal annual installments beginning on January 25, 2025. |